CGM-Parameter für das Diabetesmanagement – ein Update

Zusammenfassung Das kontinuierliche Glukosemonitoring (CGM) liefert nicht nur ein lückenloses Glukoseprofil, sondern auch Parameter wie die Zeit im Zielbereich (TiR) oder die glykämische Variabilität, womit sich die Glykämie besser beschreiben und beurteilen lässt. Die wichtigsten Parameter wurden kürzlich in einem Konsensus-Statement definiert 1. In der vorliegenden Arbeit wird die Relevanz dieser CGM-Parameter beleuchtet und dargestellt, ob sich daraus Zusammenhänge zum HbA1c-Wert aufzeigen und das Risiko für die Entwicklung diabetischer Folgeerkrankungen ableiten lassen. Ob solche Zusammenhänge einfach kausal sind, also sich nur zwischen jeweils 2 Parametern ergeben, ist zu diskutieren. Vermutlich sind diese komplexer zueinander, so dass möglicherweise nur zusammengesetzte Metriken eine ausreichende Aussage zur Prognose ermöglichen. Weiterhin wird auf die ebenfalls in dem Konsensus-Statement angeregte Analyse von CGM-Daten mit dem AGP eingegangen.

• Publication year

  2019

• Venue

  Diabetes aktuell

• Publication date

  2019-06-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1055/a-0918-0483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes

  2018cited by this paper
• Praxisbezogene Empfehlungen zum Ambulanten Glukoseprofil

  2018cited by this paper
• The Development of New Composite Metrics for the Comprehensive Analytic and Visual Assessment of Hypoglycemia Using the Hypo-Triad

  2018cited by this paper
• Praxisempfehlung der DDG: Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes

  2017cited by this paper
• International Consensus on Use of Continuous Glucose Monitoring

  2017cited by this paper
• Ambulatory glucose profile (AGP): utility in UK clinical practice

  2017cited by this paper
• Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies

  2015cited by this paper
• Threshold-based insulin-pump interruption for reduction of hypoglycemia.

  2013cited by this paper
• Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)

  2013cited by this paper
• Hypo- and Hyperglycemia in Relation to the Mean, Standard Deviation, Coefficient of Variation, and Nature of the Glucose Distribution

  2012cited by this paper
• When the Blood Glucose and the HbA1c Don’t Match: Turning Uncertainty Into Opportunity

  2012cited by this paper
• The Effect of Glycemic Variability on Counterregulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents with Type 1 Diabetes

  2011cited by this paper
• Glucose variability is associated with intensive care unit mortality*

  2010cited by this paper
• Translating the A1C Assay Into Estimated Average Glucose Values

  2008cited by this paper
• Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis

  2008cited by this paper
• Glycemic Variability: It's Not Just About A1C Anymore!

  2005cited by this paper
• Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymerase

  2004cited by this paper
• Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

  2003cited by this paper
• Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture.

  2001cited by this paper
• Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

  1996cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper

• No citing papers are available for this paper.